Skip to main content

Table 1 Comparison of ctDNA mutation analysis technologies [159]

From: Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma

Generation

Scale of analysis

Examples of technologies

Applications

Advantages

Disadvantages

First generation and next generation sequencing

Single locus or limited multiplex assays

PCR-based:

· Droplet Digital PCR (ddPCR) [140]

· BEAMING [31]

· Intplex [149]

· Detection and quantification of selected loci, cancer hotspot mutations and small number of mutations

· Widely used

· High sensitivity

· Sampling error can happen when samples need to split into multiple reactions

· Very low copy numbers of mutant DNA impairs the overall performance

· Only detects previously known mutations

Enrichment for mutant alleles:

· COLD-PCR [82]

· SCODA [95]

· NaME-PRO [136]

Next generation sequencing

Targeted sequencing assays

Amplicon-based method:

· SiMSen-Seq [144]

· TAM-Seq [38]

· Enhanced TAM-Seq [41]

· Safe-SeqS [71]

·AmpliSeq [143]

·MiSeq [69]

·NextSeq [67]

·HaloPlex [83]

· Genotyping

· Interrogating numerous mutations (SNP, CNV, insertion, deletion, structural variation)

·Individual exons of interest to the whole exome

· Reduced background error rates because of higher coverage compared to WGS

· Detection of allele fractions below 0.1%

· Even with limited amounts of input samples, sensitivity can be further enhanced

· Only detecting mutations in targeted genes/locations

· Limited detection of fusions

Hybridization capture:

· CAPP-Seq [104]

· TARDIS [97]

· SureSelect [74]

· SeqCap [26]

· HiSeq [81]

Non-targeted assays or Genome-wide

Whole genome sequencing (WGS):

· Plasma-Seq [58]

· PARE [75]

· Identification of amplifications and deletions

· Detection of fetal aneuploidies

· Investigation of genomic alterations without previously knowledge

· Characterization of the whole molecular landscape

· Limited detection in low tumour purity samples (< 25%) allele fractions sensitivity poor below low coverage

· Limited sensitivity for profiling early-stage cancer

· High cost

Amplicon-based:

· FAST-SeqS [70]

· mFast-SeqS [9]

Third generation sequencing

Targeted and whole genome sequencing

· Oxford Nanopore Technology (ONT)

· CyclomicsSeq [92]

·Detection of a wide range of variants from SNV to structural variants

· Methylation of cfDNA

· Rapid turnaround time

· Flexible accessibility

· Cost-effective

· Unrestricted read length (20 bp to 4 Mb)

· Relatively high error rates

  1. Abbreviations used in Table 1 (in alphabetical order)
  2. AmpliSeq: sequencing amplified, BEAMING: beads, emulsion, amplification, magnetics, CAPP-Seq: cancer personalized profiling by deep sequencing, COLD-PCR: co-amplification at lower denaturation temperature, FAST-SeqS: fast aneuploidy screening test-sequencing system, HaloPlex: The Agilent HaloPlex Target Enrichment System, mFAST-SeqS: modified fast aneuploidy screening test-sequencing system, NaME-PRO: nuclease-assisted minor-allele enrichment with probe-overlap, PARE: personalized analysis of rearranged ends, Safe-SeqS: safe-sequencing system, SCODA: synchronous coefficient of drag alteration, SiMSen-Seq: Simple, multiplexed, PCR-based barcoding of DNA for sensitive mutation detection using sequencing, TAM-Seq: tagged amplicon deep sequencing, TARDIS: targeted digital sequencing